These novel rhodium complexes were tested on breast cancer (MCF-7) and colon cancer (HT-29) cell lines and exhibit cytotoxicities of up to 100 times higher than Cisplatin.
Further Information: PDF
rubitec – Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum mbH
Phone: +49 (0)234/32-11969
Contact
Dietmar Tappe
